Hospital-Wide Healthcare-associated Bloodstream Infections: surveillance 2013-2014

Hospital-Wide Healthcare-associated Bloodstream Infections
Surveillance results: 2013-2014

From April 1st, 2013, to March 31st, 2014, 77 healthcare facilities took part on a voluntary basis in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,149,763 patient-days (Table 1). Participating facilities reported 2,689 BSIs in 2,495 patients. The total incidence rate was 5.4 cases per 10,000 patient-days. The incidence rate in 2013-2014 was significantly lower compared with the average rate for 2009-2013 in facilities that took part in both surveillance periods. Two teaching and 11 non-teaching facilities that were not included in the 2012-2013 study joined the program in 2013-2014. Data was extracted on May 15th, 2014. 

Update: March 9, 2017

Table 1 – Participation of Healthcare Facilities in the Hospital-Wide Surveillance of BSIs, Québec, 2009-2010 to 2013-2014

 

2009-2010

2010-2011

2011-2012

2012-2013

2013-2014
Participating facilities (N)

61

58

60

64

77
Admissions (N)

425,935

403,502

417,280

486,272

539,766
Patient-days (N)

3,407,223

3,259,186

3,275,332

3,797 385

4,149,763
BSIs (cat. 1 and 2b, N)

2,433

2,517

2,416

2,797

2,689
Infected patients (N)

2,298

2,346

2,303

2,674

2,495

In 2013-2014, the total incidence rate was 5.4 BSIs per 10,000 patient days. The incidence rates were much higher in intensive care units (ICUs) than in other units (Table 2). Catheter-related bloodstream infections (CRBSIs) were the most common BSIs in ICUs (Table 2 and Figure 2). In other units, the incidence rates varied depending on the type of healthcare facility: non-CRBSI were the most common primary BSIs in teaching facilities, while BSIs secondary to urinary tract infection were the most common in non-teaching facilities (Table 2 and Figure 3).

Figure 1 – BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Québec, 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 2 – BSI Incidence Rate in ICUs, For Each Type of Infection, by Type of Healthcare Facility and Type of ICU, Québec, 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

Figure 3 – BSI Incidence Rate in Non-ICU Units, for Each Type of Infection, by Type of Healthcare Facility, Québec, 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

Table 2 – BSI Incidence Rate for Each Type of Infection, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2012-2013 (Incidence Rate per 10,000 Patient-Days [95% CI])

 

 Primary BSIs Secondary BSIs

Total
  CRBSI Non-CRBSI Urinary tract Abdominal Pulmonary SSI Other**
Total hospitalized

1.0
[0.9 - 1.1]

1.2
[1.1 - 1.3]

1.2
[1.1 - 1.3]

0.4
[0.3 - 0.5]

0.5
[0.5 - 0.6]

0.7
[0.6 - 0.8]

0.3
[0.2 - 0.4]

5.4
[5.2 - 5.7]

Teaching

1.5
[1.4 - 1.7]

1.6
[1.4 - 1.8]

1.4
[1.2 - 1.6]

0.5
[0.4 - 0.6]

0.6
[0.5 - 0.8]

1.2
[1.0 - 1.3]

0.4
[0.3 - 0.5]

7.3
[7.0 - 7.7]
Non-teaching

0.5
[0.4 - 0.6]

0.7
[0.6 - 0.8]

1.0
[0.9 - 1.2]

0.3
[0.2 - 0.4]

0.4
[0.3 - 0.5]

0.2
[0.2 - 0.3]

0.2
  [0.2 - 0.3]

3.5
 [3.2 - 3.7]
ICUs

5.5
[4.6 - 6.5]

2.2
[1.7 - 2.8]

1.8
[1.4 - 2.4]

0.7
[0.4 – 1.0]

2.2
 [1.7 - 2.9]

1.6
[1.2 - 2.1]

0.5
[0.2 - 0.8]

14.7
[13.2 - 16.2]

Adult teaching

5.0
  [3.9 - 6.3]

2.8
 [2.0 - 3.8]

2.2
[1.5 - 3.1]

0.6
[0.3 - 1.1]

3.7
[2.7 - 4.8]

2.7
  [1.8 - 3.6]

0.6
  [0.3 - 1.1]

18.0
[15.7 - 20.4]
Adult non-teaching

3.6
[2.3 - 5.1]

1.1
  [0.5 - 2.1]

2.4
[1.4 - 3.7]

0.6
  [0.1 - 1.3]

1.0
[0.4 - 1.9]

0.9
[0.3 - 1.7]

0.3
[0.0 - 0.8]

9.8
[7.6 - 12.3]
Pediatric

12.3
  [5.6 - 21.6]

0.0*

0.0*

0.0*

0.0*

1.4
[0.0 - 5.3]

0.0*

13.6
[6.5 - 23.4]
Neonatal

8.5
[6.1 - 11.3]

2.4
[1.3 – 4.0]

0.4
[0.0 - 1.2]

1.0
[0.3 - 2.1]

0.6
[0.1 - 1.5]

0.0*

0.4
[0.0 - 1.2]

13.4
[10.4 - 16.8]
Non-ICU units

0.7
  [0.7 - 0.8]

1.1
[1.0 - 1.2]

1.2
[1.1 - 1.3]

0.4
[0.3 - 0.5]

0.4
[0.4 - 0.5]

0.7
[0.6 - 0.7]

0.3
[0.2 - 0.3]

4.8
[4.6 – 5.0]

Teaching

1.1
[0.9 - 1.2]

1.5
[1.3 - 1.7]

1.4
[1.2 - 1.5]

0.5
  [0.4 - 0.6]

0.5
[0.4 - 0.6]

1.1
[1.0 - 1.3]

0.4
 [0.3 - 0.4]

6.4
[6.1 - 6.8]
Non-teaching

0.4
[0.3 - 0.5]

0.7
[0.6 - 0.8]

1.0
[0.9 - 1.1]

0.3
[0.2 - 0.4]

0.4
[0.3 - 0.5]

0.2
[0.2 - 0.3]

0.2
[0.2 - 0.3]

3.3
[3.0 - 3.5]

* When the incidence rate is 0, the confidence interval [CI] is not calculated.
** The “Other” column also includes HD-related BSIs and secondary BSIs arising from a skin, soft tissue, bone or joint infection.

The BSI incidence rate in 2013-2014 decreased significantly compared with the 2009-2013 pooled rate (p = 0.05, Table 3). This results from the significant decrease observed in teaching facilities (p < 0.01), while incidence rates remained stable in non-teaching facilities. This downward trend was observed for every BSI type except for non-CRBSIs and BSIs secondary to a SSI (Figure 4). Observed variations were significant for CRBSI (p < 0.01), non-CRBSI (p < 0.01) and BSIs secondary to abdominal (p = 0.04) or pulmonary infections (p < 0.01).

Figure 4 – BSI Incidence Rate, by Type of Infection, in Facilities that Previously participated in Surveillance (N = 64), Québec, 2009-2013 and 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

Table 3 – BSI Incidence Rate, by Type of Healthcare Facility, in Facilities that Previously participated in Surveillance (N = 64), Québec, 2009-2013 and 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

 

Number of Facilities

Incidence Rate

2009-2013

2013-2014
Teaching facilities 

22

8.2 [7.9 - 8.4]

7.4 [7.0 - 7.8]
Non-teaching facilities 

42

3.7 [3.5 - 3.8]

3.7 [3.4 - 4.0]

Total

64

6.0 [5.9 - 6.1]

5.7 [5.5 - 6.0]

Patients who developed a BSI were aged between 0 and 101 years, with a median age of 68 years. Although the incidence rates were higher in ICUs, most of the BSIs occurred in non-ICU units (70%, Table 4 and Figure 5). CRBSIs were the most commonly encountered BSIs in ICUs, whereas BSIs secondary to urinary tract infections were the most common in non-ICU units. Similarly, CRBSIs were the most frequent type of BSI in teaching facilities, whereas BSIs originating from a urinary tract infection ranked first among non-teaching facilities (Table 4 and Figure 6).

Figure 5 – Breakdown of Cases Based on Type of Unit and Type of ICU, Québec, 2013-2014 (%)

Figure 6 – Breakdown of Cases Based on Type of BSI, for Teaching and Non-Teaching Healthcare Facilities, Québec, 2013-2014 (%)

Table 4 – Number of Cases for Each Type of BSI, by Type of Healthcare Facility, Type of Unit and Type of ICU, Québec, 2013-2014 (N)

 

 Primary BSIs Secondary BSIs

Total

 

CRBSI

Non-CRBSI

HD

 Urinary tract Abdominal Pulmonary SSI Other**

Total

507           

618           

137           

568           

178           

229           

309           

143           

2,689           

Teaching

381           

429           

96           

317           

111           

140           

257           

85           

1,816           
Non-teaching

126           

189           

41           

251           

67             

89                 

52           

58           

873           
Total hospitalized

426           

483           

23           

506           

169           

222           

300           

123           

2,252           

Teaching

322           

338           

18           

293           

106           

137           

250           

78           

1,542           
Non-teaching

104           

145           

5           

213           

63              

85           

50           

45

710
ICU

140           

56           

4           

47           

17              

57           

41           

12           

374           

Adult, teaching 

64           

36           

4           

28           

8              

47           

34           

8           

229           
Adult, non-teaching 

25           

8           

0           

17           

4              

7      

6           

2           

69           
Pediatric

9           

0           

0           

0           

0                  

0                

1           

0           

10           
Neonatal

42           

12           

0           

2           

5                 

3                  

0           

2           

66           
Non-ICU hospitalization

286           

427           

19           

459           

152           

165           

259           

111           

1,878           

Teaching

207           

290           

14           

263           

93         

87                

215           

68           

1,237           
Non-teaching

79           

137           

5           

196           

59              

78                   

44           

43           

641           
Ambulatory

81           

135           

114           

62           

9           

7          

9           

20           

437           

Teaching

59           

91           

78           

24           

5           

3           

7           

7           

274           
Non-teaching

22           

44           

36           

38           

4           

4           

2           

13           

163           

* The “Other” column also includes BSIs secondary to skin, soft tissue, bone or joint infection

Overall, 17% of BSI cases resulted in death within 30 days of bacteremia onset (Table 5). Case fatality was highest in patients with a BSI secondary to a pulmonary infection (Table 5 and Figure 7).

Table 5 – 10-Day and 30-Day Case Fatality for Each Type of Infection, 2013-2014 (N, %)

 

 BSIs 10-day case fatality 30-day case fatality

 

N

%

N

%
Primary BSIs          
   CRBSI

507

43

8

69

14
   Non-CRBSI

618

60

10

99

16
   HD

137

14

10

21

15
Secondary BSIs          
   Urinary tract

568

43

8

84

15
   Abdominal

178

30

17

44

25
   Pulmonary 

229

63

28

85

37
   SSI

309

15

5

30

10
   Skin and soft tissue

70

5

7

8

11
   Bone and joint

16

0

0

1

6
   Other

57

5

9

10

18

Total

2,689

278

10

451

17

Figure 7 – 30-Day Case Fatality for Each Type of Infection, Québec, 2013-2014 (%)

The two most frequently isolated microorganisms in reported cases and in cases resulting in death within 30 days were Staphylococcus aureus and Escherichia coli (Figure 8 and Table 6). Staphylococcus aureus was the most frequently isolated microorganism in patients with a CRBSI, a dialysis-related BSI and in BSIs secondary to a SSI (Figure 9 and Table 6). In patients with a non-CRBSI or a BSI secondary to a urinary tract, pulmonary or abdominal infection, Enterobacteriaceae were the most common microorganisms. In cases of hemodialysis and BSIs secondary to a pulmonary infection or an SSI, S. aureus ranked first. A polymicrobial infection occurred in 7% of cases.

Figure 8 – Breakdown of Categories of Isolated Microorganisms in All Cases (N = 2,923) and Cases of Fatality Within 30 Days (N = 495), Québec, 2013-2014 (%)

Figure 9 – Breakdown of Categories of Isolated Microorganisms, for Each Type of BSI, Québec, 2013-2014 (%)

Table 6 – Breakdown of Microorganisms associated with BSIs, for each Type of BSI, for all BSIs and for those associated with a Fatality Within 30 Days, Québec, 2013-2014 (N, %)

Microorganism

Primary BSIs

Secondary BSIs

Overall*

30-Day Case Fatality  

CRBSI

Non-CRBSI

HD

Urinary tract

Abdominal

Pulmonary

SSI

N

%
Enterobacteria

67

341

18

425

95

73

86

1,141

167

14.6
   E. coli

12

179

2

279

46

26

40

601

84

14.0
   Klebsiella sp.

24

93

3

79

34

31

21

294

46

15.6
Other enterobacteriaceae

31

69

13

67

15

16

25

246

37

15.0
S. aureus

174

78

83

38

5

68

103

606

117

19.3
CNS

139

26

13

13

2

6

12

215

21

9.8
Enterococcus sp.

59

75

9

54

39

10

23

278

56

20.1
Candida sp.

57

29

2

21

15

4

19

150

50

33.3
Anaerobic

2

28

1

2

12

4

41

95

10

10.5
Pseudomonas sp.

10

31

3

35

9

26

10

132

23

17.4
S. lugdunensis

2

0

3

2

0

1

1

9

2

22.2
Other

48

86

10

14

21

52

38

297

49

16.5

Total

558

694

142

604

198

244

333

2,923

495

16.9

* This column includes the sum of the other columns as well as secondary BSIs arising from a skin, soft tissue, bone or joint infection, or another source.

Methicillin-resistant S. aureus (MRSA) accounted for 17% (101/602) of S. aureus BSIs in all geographic areas. This proportion has been decreasing on a fairly constant basis since 2009 (Table 7 and Figure 10). Resistance to vancomycin was relatively stable in Enterococcus faecium and E. faecalis BSIs (5%), compared to 2009-2013. BSIs associated with carbapenem-resistant enterobacteriaceae continued to be relatively rare in Québec.

Table 7 – Proportion of Strains Tested and Proportion of Resistance to Antibiotics for Selected Isolated Microorganisms, Québec, 2013-2014 (N, %)

Microorganism

Antibiotic

Isolated
N

Tested

Resistant

N

%

N

%

Staphylococcus aureus

Oxacillin

606

602

99.3

101

16.8

Enterococcus faecium

 Vancomycin

78

78

100.0

10

12.8

Enterococcus faecalis

 Vancomycin

142

141

99.3

0

0.0

Klebsiella (pneumoniae-oxytoca)

 CSE 4

8

7

87.5

0

0.0
Imipenem or meropenem

8

4

50.0

0

0.0
Multiresistant 1

8

8

100.0

0

0.0

Escherichia coli

 CSE 4

601

507

84.4

68

13.4
Fluoroquinolones 3

601

548

91.2

145

26.5
Imipenem or meropenem

601

163

27.1

0

-
Multiresistant 1

601

536

89.2

39

7.3

Enterobacter sp.

 CSE 4

133

110

82.7

16

14.5
Imipenem or meropenem

133

80

60.2

0

0.0
Multiresistant 1

133

106

79.7

1

0.9

Pseudomonas sp.

 Amikacin, gentamicin or tobramycin

132

109

82.6

4

3.7
CSE 2

132

122

92.4

9

7.4
Fluoroquinolones 2

132

125

94.7

13

10.4
Imipenem or meropenem

132

113

85.6

14

12.4
Piperacillin/tazobactam

132

100

75.8

6

6.0
Multiresistant 2

132

126

95.5

9

7.1

Acinetobacter sp.

 Imipenem or meropenem

13

6

46.2

0

0.0
Multiresistant 3

13

6

46.2

0

0.0

CSE 4: cefepime, cefotaxime, ceftazidime or ceftriaxone; CSE 2: cefepime or ceftazidime. 
Fluoroquinolones 3: ciprofloxacin, levofloxacin or moxifloxacin; Fluoroquinolones 2: ciprofloxacin or levofloxacin;   
Multiresistant 1: intermediate or resistant to an agent in three of the following five categories: cephalosporins 4, fluoroquinolones 3, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam.
Multiresistant 2: intermediate or resistant to an agent in three of the following five categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam.
Multiresistant 3: intermediate or resistant to an agent in three of the following six categories: cephalosporins 2, fluoroquinolones 2, aminoglycosides, carbapenems, piperacillin or piperacillin/tazobactam, ampicillin/sulbactam.

Figure 10 – Antibiotic Resistance in Gram-Positive Bacteria, Gram-Negative Bacteria and Pseudomonas sp., Québec, 2009-2013 to 2013-2014 (%)

The incidence rate distribution for teaching facilities decreased markedly compared to the background distribution from 2009-2010 to 2012-2013 (Table 8 and Figure 11). This is not the case in non-teaching facilities, despite the addition of 11 new healthcare facilities (Table 9 and Figure 12). We recommend that facilities compare their current rates with their own rates from previous years, as well as with figures reported by comparable facilities (teaching or non-teaching).

Figure 11 – BSI Incidence Rate per Facility (2013-2014) and Percentile Ranking (2009-2010 to 2012-2013) for Teaching Healthcare Facilities, Québec, 2013-2014

Figure 12 – BSI Incidence Rate per Facility (2013-2014) and Percentile Ranking (2009-2010 to 2012-2013) for Non-Teaching Healthcare Facilities, Québec, 2013-2014

Table 8 – BSI Incidence Rate per Facility and Percentile Ranking, for Teaching Healthcare Facilities, Québec, 2009-2013 to 2013-2014 (Incidence Rate per 10,000 Patient-Days [95% CI])

Facility

2009-2013

2013-2014

1

HÔPITAL CHARLES LEMOYNE

5.0

[4.4 - 5.6]

4.8

[3.7 - 6.1]

2

HÔPITAL DE L'ENFANT-JÉSUS

8.8

[7.3 - 10.5]

8.5

[7.0 - 10.2]

3

HÔPITAL ROYAL VICTORIA

14.5

[13.5 - 15.6]

14.5

[12.4 - 16.8]

4

HÔPITAL NOTRE-DAME DU CHUM

11.9

[11.0 - 12.9]

10.1

[8.4 - 12.0]

6

L'HÔPITAL DE MONTRÉAL POUR ENFANTS

13.6

[11.7 - 15.5]

15.8

[11.9 - 20.3]

7

PAVILLON L'HÔTEL-DIEU DE QUÉBEC

12.0

[10.7 - 13.5]

13.5

[11.2 - 16.1]

8

PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX

8.2

[7.5 - 8.9]

7.3

[6.1 - 8.6]

13

INSTITUT DE CARDIOLOGIE DE MONTRÉAL

-

  

1.6

[0.6 - 3.1]

15

HÔPITAL FLEURIMONT

6.5

[5.8 - 7.3]

6.4

[5.0 – 8.0]

18

HÔTEL-DIEU DE LÉVIS

8.0

[5.6 - 10.8]

7.5

[5.1 - 10.3]

20

HÔPITAL DE CHICOUTIMI

3.5

[2.9 - 4.1]

4.9

[3.6 - 6.5]

21

HÔPITAL SAINT-LUC DU CHUM

16.9

[15.6 - 18.2]

13.4

[11.2 - 15.7]

22

HÔTEL-DIEU DU CHUM

10.0

[8.9 - 11.1]

10.1

[8.0 - 12.4]

24

HÔPITAL DU SAINT-SACREMENT

1.6

[0.7 - 2.8]

1.1

[0.4 - 2.1]

25

HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL

7.6

[6.9 - 8.4]

7.3

[6.0 - 8.8]

27

PAVILLON CH DE L'UNIVERSITÉ LAVAL

2.5

[1.9 - 3.1]

4.1

[3.1 - 5.3]

28

PAVILLON SAINT-FRANÇOIS D'ASSISE

4.4

[3.6 - 5.2]

4.0

[2.8 - 5.4]

29

HÔPITAL GÉNÉRAL DE MONTRÉAL

10.4

[9.5 - 11.4]

7.5

[5.8 - 9.4]

30

HÔTEL-DIEU DE SHERBROOKE

5.8

[4.9 - 6.7]

4.7

[3.2 - 6.5]

31

PAVILLON SAINT-JOSEPH

4.4

[3.8 - 5.0]

5.3

[4.1 - 6.6]

33

INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

4.8

[4.1 - 5.5]

3.2

[2.1 - 4.4]

116

INSTITUT THORACIQUE DE MONTRÉAL

3.5

[2.4 - 4.8]

0.5

[0.0 - 1.9]

118

HÔPITAL NEUROLOGIQUE DE MONTRÉAL

4.1

[2.9 - 5.5]

2.0

[0.6 - 4.2]
 

10th percentile

3.1

1.7
 

25th percentile

4.6

1.4
 

50th percentile

6.9

2.8
 

74th percentile

11.0

3.8
 

90th percentile

14.3

4.8

Table 9 – BSI Incidence Rate per Facility and Percentile Ranking, for Non-Teaching Healthcare Facilities, Québec, 2008-2012 to 2012-2013 (Incidence Rate per 10,000 Patient-Days [95% CI])

Facility

2009-2013

2013-2014

9

HÔPITAL DU HAUT-RICHELIEU

6.5

[5.7 - 7.4]

4.6

[3.3 - 6.1]

10

HÔPITAL PIERRE-BOUCHER

4.6

[3.7 - 5.6]

2.6

[1.7 - 3.7]

11

HÔPITAL PIERRE-LE GARDEUR

3.4

[2.9 - 4.0]

5.2

[3.9 - 6.7]

14

CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE

5.4

[4.6 - 6.2]

6.7

[5.1 - 8.5]

16

HÔPITAL RÉGIONAL DE RIMOUSKI

5.8

[4.8 - 6.8]

5.3

[3.5 - 7.5]

23

HÔTEL-DIEU D'ARTHABASKA

2.9

[2.2 - 3.6]

2.9

[1.6 - 4.5]

26

HÔPITAL DE VERDUN

5.6

[4.8 - 6.5]

4.1

[2.8 - 5.7]

32

CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE

3.8

[2.8 - 4.9]

5.1

[2.8 - 8.0]

34

HÔPITAL SANTA CABRINI

-

  

3.9

[2.8 - 5.1]

35

HÔPITAL HONORÉ-MERCIER

-

  

2.2

[1.2 - 3.5]

37

HÔTEL-DIEU DE SOREL

4.0

[3.2 - 5.0]

3.3

[1.9 - 5.1]

38

HÔPITAL JEAN-TALON

6.1

[5.2 - 7.1]

4.4

[2.8 - 6.4]

39

HÔPITAL DE GATINEAU

2.5

[1.9 - 3.2]

3.3

[2.1 - 4.9]

40

HÔPITAL DE HULL

3.2

[2.6 - 3.9]

4.9

[3.3 - 6.7]

41

HÔPITAL DU CENTRE-DE-LA-MAURICIE

2.6

[1.9 - 3.4]

1.0

[0.3 - 2.1]

42

HÔPITAL ANNA-LABERGE

-

  

2.8

[1.8 - 4.1]

44

HÔPITAL SAINTE-CROIX

3.3

[2.6 - 4.1]

2.9

[1.7 - 4.4]

45

HÔPITAL DE SAINT-EUSTACHE

2.9

[2.3 - 3.5]

3.5

[2.4 - 4.9]

46

HÔPITAL DE GRANBY

2.3

[1.7 - 3.1]

1.9

[0.8 - 3.4]

47

HÔPITAL DE ROUYN-NORANDA

1.7

[1.0 - 2.6]

4.7

[2.3 - 7.9]

49

CSSS MEMPHRÉMAGOG

-

  

0.7

[0.0 - 2.8]

52

CH HÔTEL-DIEU D'AMOS

1.9

[1.1 - 2.8]

1.4

[0.3 - 3.5]

53

HÔPITAL DE CHANDLER

3.7

[2.3 - 5.4]

3.6

[1.1 - 7.5]

56

CENTRE DE SANTÉ ET DE SERVICES SOCIAUX D'ARGENTEUIL

-

  

2.8

[0.3 - 8.1]

58

HÔPITAL DU SUROÎT

4.4

[3.6 - 5.3]

4.4

[2.9 - 6.2]

59

HÔPITAL DE BAIE-SAINT-PAUL

-

  

0.0

  

61

HÔPITAL NOTRE-DAME-DE-FATIMA

1.0

[0.3 - 2.3]

0.0

  

63

HÔPITAL DE SAINT-GEORGES

3.1

[2.3 - 3.9]

4.0

[2.3 - 6.2]

64

HÔPITAL LE ROYER

1.8

[1.1 - 2.7]

1.5

[0.4 - 3.4]

67

HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE

2.0

[1.4 - 2.8]

1.0

[0.3 - 2.3]

71

HÔPITAL DE MATANE

0.6

[0.1 - 1.4]

0.0

  

72

HÔPITAL ET CENTRE D'HÉBERGEMENT DE SEPT-ÎLES

2.4

[1.4 - 3.8]

2.9

[1.1 - 5.4]

74

HÔPITAL DE DOLBEAU-MISTASSINI

2.9

[1.8 - 4.3]

1.9

[0.4 - 4.7]

75

CSSS DU GRANIT

-

  

2.1

[0.2 - 5.9]

77

HÔPITAL D'AMQUI

1.9

[0.8 - 3.6]

0.0

  

81

HÔPITAL DE MONT-LAURIER

1.7

[0.9 - 2.9]

3.5

[1.3 - 7.0]

82

PAVILLON SAINTE-FAMILLE

-

  

0.0

  

84

HÔPITAL DE NOTRE-DAME-DU-LAC

0.0

  

2.4

[0.2 - 6.8]

85

CSSS DU HAUT-SAINT-MAURICE

0.6

[0.1 - 1.9]

0.0

  

86

HÔPITAL DE LA MALBAIE

-

  

2.3

[0.2 - 6.5]

88

HÔPITAL. CLSC ET CENTRE D'HÉBERGEMENT DE ROBERVAL

3.0

[2.1- 4.0]

2.6

[1.1 - 4.8]

89

HÔPITAL DE MONTMAGNY

2.2

[1.3 - 3.3]

3.2

[1.2 - 6.4]

91

HÔPITAL HÔTEL-DIEU DE GASPÉ

3.0

[1.6 - 4.8]

3.9

[1.0 - 8.6]

95

HÔPITAL DU PONTIAC

    

0.0

  

96

CENTRE DE SANTÉ DE CHIBOUGAMAU

0.4

[0.0 - 1.4]

3.1

[0.3 - 8.9]

99

HÔPITAL BROME-MISSISQUOI-PERKINS

3.6

[2.6 - 4.8]

2.8

[1.2 - 5.1]

101

HÔPITAL RÉGIONAL DE SAINT-JÉRÔME

5.1

[4.4 - 5.8]

5.6

[4.3 - 7.1]

103

HÔPITAL LAURENTIEN

1.2

[0.7 - 1.9]

0.7

[0.1 - 2.1]

107

HÔPITAL DE L'ARCHIPEL

1.4

[0.1 - 3.9]

0.0

  

109

HÔPITAL DE SAINTE-ANNE-DES-MONTS

1.2

[0.3 - 2.7]

1.2

[0.0 - 4.8]

111

HÔPITAL DE PAPINEAU

0.8

[0.3 - 1.5]

1.5

[0.3 - 3.6]

112

HÔPITAL D'ALMA

3.0

[2.1 - 4.0]

3.1

[1.5 - 5.3]

113

HÔPITAL DE THETFORD MINES

-

  

2.8

[1.1 - 5.2]

130

HÔPITAL BARRIE MEMORIAL

-

  

1.6

[0.1 - 4.5]

 

10th percentile

0.0

0.0
 

25th percentile

1.4

1.4
 

50th percentile

2.7

2.8
 

74th percentile

3.9

3.8

 

90th percentile

5.7

4.8

CRBSI: catheter-related bloodstream infection
HD: hemodialysis
95% CI: 95% confidence interval
SSI: surgical site infection
Non-CRBSI: non-catheter-related primary bloodstream infection
CoNS: coagulase-negative Staphylococcus
ICU: intensive care unit

Comité de surveillance provinciale des infections nosocomiales (SPIN) – bactériémies panhospitalières

Editorial Committee 

Alex Carignan, Centre hospitalier universitaire de Sherbrooke

Élise Fortin, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Isabelle Rocher, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Version EPUB